Upland Software to Release Fourth Quarter and Full Year 2018 Financial Results on March 7, 2019
Upland Software, Inc. (Nasdaq: UPLD), a leader in cloud-based Enterprise Work Management software, today announced
News
Rayonier Announces First Quarter 2019 Dividend
Rayonier Inc. (NYSE:RYN) announced today that the companys board of directors has declared a first
AM Best Affirms Credit Ratings of Guild Insurance Limited
AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer
Volkswagen Protects Virtual Key Sharing App with Trustonic Application Protection
Volkswagen is working with mobile cyber security leader Trustonic to enable customers to use smartphones
Pinnacle West Reports 2018 Full-Year and Fourth-Quarter Results
Pinnacle West Capital Corporation (NYSE: PNW) today reported consolidated net income attributable to common shareholders
KBRA Publishes RMBS Research: Evaluating Prime 2.0 Subordinate Liquidity Risk in Slow CPR Scenarios
Kroll Bond Rating Agency (KBRA) takes an in-depth look at the prominent shifting-interest structural mechanism
Imbrium Therapeutics Announces U.S. FDA Orphan Drug Designation for Etoposide Toniribate for the Treatment of Relapsed Refractory Biliary Tract Cancer
Imbrium Therapeutics L.P., a clinical-stage biopharmaceutical company and operating subsidiary of Purdue Pharma L.P., in
Granite Awarded $22 Million Highway Contract in California
Granite (NYSE:GVA) announced today that it has been awarded a $22 million contract by the
The Marketing Alliance Announces Financial Results for its Fiscal 2019 Third Quarter Ended December 31, 2018
The Marketing Alliance, Inc. (OTC: MAAL) (TMA or the Company), today announced financial results for
Mundipharma EDO GmbH: US FDA grants Orphan Drug Designation for etoposide toniribate in relapsed/refractory biliary tract cancer
Mundipharma EDO GmbH, part of the Mundipharma network of independent associated companies, and Imbrium Therapeutics
Cerus to Participate In Upcoming Investor Conferences
Cerus Corporation (Nasdaq:CERS) announced today that the Company will participate in two upcoming investor conferences.
Tel-Instrument Electronics Corp. Receives $641,172 Mode 5 Test Set Order for the U.S. Navy
Tel-Instrument Electronics Corp. (Tel, Tel-Instrument or the Company) (NYSE American: TIK), a leading designer and
